IL6 and cancer: Patients referred to the diagnostic unit, with a cancer diagnosis, with only elevated IL‐6, CEA, CA 19‐9 or CA‐125 had significantly shorter OS than patients with a cancer diagnosis, without elevated biomarkers (Figure S2).